Deutsch English Français

Contact

EP2900806

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2900806

EP2900806 - THREE-DIMENSIONAL CELL CULTURING [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 17.09.2021 Database last updated on 30.07.2024
Former	The patent has been granted Status updated on 09.10.2020
Former	Grant of patent is intended Status updated on 13.07.2020
Former	Examination is in progress Status updated on 24.03.2017
Most recent event Tooltip	27.04.2024	Lapse of the patent in a contracting state New state(s): MK	published on 29.05.2024 [2024/22]
Applicant(s)	For all designated states UPM-Kymmene Corporation Alvar Aallon katu 1 00100 Helsinki / FI
	[2015/32]
Inventor(s)	01 / LAUKKANEN, Antti Mannerheimintie 35 A5 FI-00250 Helsinki / FI
	02 / LOU, Yan-Ru Shengrong Road No.288 Building 6,Room 617 201210 Shanghai / CN
	03 / YLIPERTTULA, Marjo Kattilavuorenkuja 2 FI-02330 Espoo / FI
	04 / KUISMA, Tytti Heikunantie 3 Q FI-02680 Espoo / FI
	05 / NIKLANDER, Johanna Faculty of Pharmacy P.O.Box 56 FI-00014 The University of Helsinki / FI
	06 / PERE, Jaakko Rekitie 5 B FI-01240 Vantaa / FI
	[2020/45]
Former [2015/32]	01 / LAUKKANEN, Antti Minna Canthin katu 24 as. 11 FI-00250 Helsinki / FI
	02 / LOU, Yan-Ru Tilanhoitajankaari 14 A 21 FI-00790 Helsinki / FI
	03 / YLIPERTTULA, Marjo Kattilavuorenkuja 2 FI-02330 Espoo / FI
	04 / KUISMA, Tytti Ounasvaarankuja 1 C 41 FI-00970 Helsinki / FI
	05 / NIKLANDER, Johanna Faculty of Pharmacy P.O.Box 56 FI-00014 The University of Helsinki / FI
	06 / PERE, Jaakko Rekitie 5 B FI-01240 Vantaa / FI
Representative(s)	Boco IP Oy Ab Kansakoulukatu 3 00100 Helsinki / FI
	[N/P]
Former [2015/32]	Boco IP Oy Ab Itämerenkatu 5 00180 Helsinki / FI
Application number, filing date	13779620.7	24.09.2013
	[2020/46]
	WO2013FI50928
Priority number, date	FI20120005997	25.09.2012 Original published format: FI 20125997
	[2015/32]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2014049204
	Date:	03.04.2014
	Language:	EN
	[2014/14]
	Type:	A1 Application with search report
	No.:	EP2900806
	Date:	05.08.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.04.2014 takes the place of the publication of the European patent application.
	[2015/32]
	Type:	B1 Patent specification
	No.:	EP2900806
	Date:	11.11.2020
	Language:	EN
	[2020/46]
Search report(s)	International search report - published on:	EP	03.04.2014
Classification	IPC:	C12N5/00	[2015/32]
	CPC:	C12M23/14 (EP,IL); C12N5/0018 (FI,IL); C08L1/02 (FI,IL); C12N5/0602 (IL,US); C12N5/0062 (EP,IL,US); C12N5/0606 (EP,FI,IL,US); (+) C12N5/0696 (EP,FI,IL,US); C12N2500/92 (EP,IL,US); C12N2533/78 (EP,IL,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/32]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	DREIDIMENSIONALE ZELLKULTIVIERUNG	[2015/32]
	English:	THREE-DIMENSIONAL CELL CULTURING	[2015/32]
	French:	CULTURE DE CELLULES TRIDIMENSIONNELLES	[2015/32]
Entry into regional phase	24.04.2015	National basic fee paid
	24.04.2015	Designation fee(s) paid
	24.04.2015	Examination fee paid
Examination procedure	24.04.2015	Examination requested [2015/32]
	06.11.2015	Amendment by applicant (claims and/or description)
	27.03.2017	Despatch of a communication from the examining division (Time limit: M06)
	02.10.2017	Reply to a communication from the examining division
	13.04.2018	Despatch of a communication from the examining division (Time limit: M04)
	13.08.2018	Reply to a communication from the examining division
	20.01.2020	Date of oral proceedings
	05.02.2020	Despatch of a communication from the examining division (Time limit: M02)
	05.02.2020	Minutes of oral proceedings despatched
	02.03.2020	Reply to a communication from the examining division
	14.07.2020	Communication of intention to grant the patent
	29.09.2020	Fee for grant paid
	29.09.2020	Fee for publishing/printing paid
	29.09.2020	Receipt of the translation of the claim(s)
Divisional application(s)	EP20152583.9 / EP3699264
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.03.2017
Opposition(s)	12.08.2021	No opposition filed within time limit [2021/42]
Fees paid	Renewal fee
	28.09.2015	Renewal fee patent year 03
	27.09.2016	Renewal fee patent year 04
	27.09.2017	Renewal fee patent year 05
	27.09.2018	Renewal fee patent year 06
	27.09.2019	Renewal fee patent year 07
	28.09.2020	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	24.09.2013
	AL	11.11.2020
	AT	11.11.2020
	CY	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	ES	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	MC	11.11.2020
	MK	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
	[2024/22]
Former [2023/30]	HU	24.09.2013
	AL	11.11.2020
	AT	11.11.2020
	CY	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	ES	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	MC	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2023/29]	HU	24.09.2013
	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	ES	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	MC	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2022/25]	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	ES	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	MC	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2022/23]	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	ES	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2022/10]	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	ES	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	PT	11.03.2021
Former [2021/51]	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	ES	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/50]	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SI	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/48]	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	HR	11.11.2020
	IT	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/45]	AL	11.11.2020
	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	HR	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/36]	AT	11.11.2020
	CZ	11.11.2020
	EE	11.11.2020
	HR	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/35]	AT	11.11.2020
	CZ	11.11.2020
	HR	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RO	11.11.2020
	RS	11.11.2020
	SK	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/34]	AT	11.11.2020
	CZ	11.11.2020
	HR	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RS	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/33]	AT	11.11.2020
	HR	11.11.2020
	LT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RS	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/32]	AT	11.11.2020
	HR	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RS	11.11.2020
	SM	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/28]	AT	11.11.2020
	HR	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RS	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/25]	AT	11.11.2020
	LV	11.11.2020
	PL	11.11.2020
	RS	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	IS	11.03.2021
	PT	11.03.2021
Former [2021/24]	AT	11.11.2020
	LV	11.11.2020
	RS	11.11.2020
	BG	11.02.2021
	NO	11.02.2021
	GR	12.02.2021
	PT	11.03.2021
Former [2021/23]	LV	11.11.2020
	RS	11.11.2020
	NO	11.02.2021
	GR	12.02.2021
	PT	11.03.2021
Former [2021/22]	RS	11.11.2020
	NO	11.02.2021
	PT	11.03.2021
Former [2021/21]	PT	11.03.2021
Cited in	International search	[A]US2010124783 (CHEN YA XIONG [US], et al)[A] 1-35;
		[XI]WO2012056109 (UPM KYMMENE CORP [FI], et al) [X] 1,6,7,9-18,21,23,26-31 * example - * [I] 2-5,8,19,20,22,24,25,32-35;
		[XI]WO2012056110 (UPM KYMMENE CORP [FI], et al) [X] 1,7,9-18,21,23,26-31 * example - * [I] 2-6,8,19,20,22,24,25,32-35;
		[XI] - BHATTACHARYA M ET AL, "Nanofibrillar cellulose hydrogel promotes three-dimensional liver cell culture", JOURNAL OF CONTROLLED RELEASE, (201212), vol. 164, no. 3, doi:10.1016/j.jconrel.2012.06.039, ISSN 0168-3659, pages 291 - 298, XP055057348 [X] 1,6,7,9-15,21,23 * the whole document * [I] 2-5,8,20,22,24-35 DOI: http://dx.doi.org/10.1016/j.jconrel.2012.06.039
	by applicant	US5254471
		WO2004007683
		US7449180
		WO2009126980
		EP1970436
		- AHOLA, S.; TURON, X.; OSTERBERG, M.; LAINE, J.; ROJAS, O.J., LANGMUIR, (2008), vol. 24, pages 11592 - 11599
		- THOMSON, J.A. ET AL., "Embryonic stem cell lines derived from human blastocysts", SCIENCE, (1998), vol. 282, doi:doi:10.1126/science.282.5391.1145, pages 1145 - 1147, XP002933311 DOI: http://dx.doi.org/10.1126/science.282.5391.1145
		- TAKAHASHI, K. ET AL., "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", CELL, (2007), vol. 131, doi:doi:10.1016/j.cell.2007.11.019, pages 861 - 872, XP002555952 DOI: http://dx.doi.org/10.1016/j.cell.2007.11.019
		- YU, J. ET AL., "Induced pluripotent stem cell lines derived from human somatic cells", SCIENCE, (2007), vol. 318, doi:doi:10.1126/science.1151526, pages 1917 - 1920, XP055435356 DOI: http://dx.doi.org/10.1126/science.1151526
		- XU, C. ET AL., "Feeder-free growth of undifferentiated human embryonic stem cells", NATURE BIOTECHNOLOGY, (2001), vol. 19, doi:doi:10.1038/nbt1001-971, pages 971 - 974, XP002672078 DOI: http://dx.doi.org/10.1038/nbt1001-971
		- LUDWIG, T.E. ET AL., "Derivation of human embryonic stem cells in defined conditions", NATURE BIOTECHNOLOGY, (2006), vol. 24, doi:doi:10.1038/nbt1177, pages 185 - 187, XP002564246 DOI: http://dx.doi.org/10.1038/nbt1177
		- BRAAM, S.R. ET AL., "Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin", STEM CELLS, (2008), vol. 26, doi:doi:10.1634/stemcells.2008-0291, pages 2257 - 2265, XP007912130 DOI: http://dx.doi.org/10.1634/stemcells.2008-0291
		- RODIN, S. ET AL., "Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511", NATURE BIOTECHNOLOGY, (2010), vol. 28, pages 611 - 615
		- MELKOUMIAN, Z. ET AL., "Synthetic peptide-acrylate surfaces for long-term self- renewal and cardiomyocyte differentiation of human embryonic stem cells", NATURE BIOTECHNOLOGY, (2010), vol. 28, doi:doi:10.1038/NBT.1629, pages 606 - 610, XP002636474 DOI: http://dx.doi.org/10.1038/NBT.1629
		- VILLA-DIAZ, L.G. ET AL., "Synthetic polymer coatings for long-term growth of human embryonic stem cells", NATURE BIOTECHNOLOGY, (2010), vol. 28, doi:doi:10.1038/nbt.1631, pages 581 - 583, XP055019660 DOI: http://dx.doi.org/10.1038/nbt.1631
		- WALTHER, A.; TIMONEN, J.V.; DIEZ, I.; LAUKKANEN, A.; IKKALA, O, "Multifunctional high-performance biofibers based on wet-extrusion of renewable native cellulose nanofibrils", ADV MATER, (2011), vol. 23, doi:doi:10.1002/adma.201100580, pages 2924 - 2928, XP055002551 DOI: http://dx.doi.org/10.1002/adma.201100580
		- PAHIMANOLIS, N. ET AL., "Surface functionalization of nanofibrillated cellulose using click-chemistry approach in aqueous media", CELLULOSE, (2011), vol. 18, doi:doi:10.1007/s10570-011-9573-4, pages 1201 - 1212, XP019936840 DOI: http://dx.doi.org/10.1007/s10570-011-9573-4
		- FILPPONEN, I. ET AL., "Generic method for modular surface modification of cellulosic materials in aqueous medium by sequential ''click'' reaction and adsorption", BIOMACROMOLECULES, (2012), vol. 13, doi:doi:10.1021/bm201661k, pages 736 - 742, XP055031857 DOI: http://dx.doi.org/10.1021/bm201661k
		- YU, J. ET AL., "Human induced pluripotent stem cells free of vector and transgene sequences", SCIENCE, (2009), vol. 324, pages 797 - 801

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p